BCI-121 T5322
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BCI-121 is a substrate-competitive SMYD3 inhibitor that inhibits the proliferation of the cancer cell.
CAS nr:
432529-82-3
Purity:
98%
Molecular Weight:
340,22
SMILES:
NC(=O)C1CCN(CC(=O)Nc2ccc(Br)cc2)CC1
Formula:
C14H18BrN3O2
Pathway:
Chromatin/Epigenetic
Target:
Histone Methyltransferase
